NCGFX
Price
$63.57
Change
-$2.06 (-3.14%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

NCGFX vs VFINX

Header iconNCGFX vs VFINX Comparison
Open Charts NCGFX vs VFINXBanner chart's image
New Covenant Growth
Price$63.57
Change-$2.06 (-3.14%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
NCGFX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NCGFX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCGFX is a Hold and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. NCGFX (525M). VFINX pays higher dividends than NCGFX: VFINX (1.24) vs NCGFX (0.74). NCGFX was incepted earlier than VFINX: NCGFX (25 years) vs VFINX (48 years). NCGFX is a more actively managed with annual turnover of: 7.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than NCGFX: VFINX (0) vs NCGFX (500). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. NCGFX (16.38). VFINX return over 5 years is better than : 88.65 vs. NCGFX (52.73).
NCGFXVFINXNCGFX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years48 years-
Gain YTD15.46327.27557%
Front LoadN/AN/A-
Min. Initial Investment5000-
Min. Initial Investment IRAN/AN/A-
Net Assets525M1.37T0%
Annual Yield % from dividends0.741.2460%
Returns for 1 year16.3827.6359%
Returns for 3 years12.1530.9939%
Returns for 5 years52.7388.6559%
Returns for 10 years88.35193.6246%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc